Westlake Chemical Partners LP

NYSE WLKP

Westlake Chemical Partners LP EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 396.23 M

Westlake Chemical Partners LP EBIT is USD 396.23 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 8.79% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Westlake Chemical Partners LP EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 364.20 M, a -7.53% change year over year.
Westlake Chemical Partners LP EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 393.87 M, a 13.31% change year over year.
Westlake Chemical Partners LP EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 347.59 M, a -6.67% change year over year.
Westlake Chemical Partners LP EBIT for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 372.42 M, a 8.23% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NYSE: WLKP

Westlake Chemical Partners LP

CEO	Mr. Jean-Marc Gilson
IPO Date	July 30, 2014
Location	United States
Headquarters	2801 Post Oak Boulevard
Employees	2,169
Sector	Industrials
Industries Petrochemicals Oil & Gas Oil Refining

Description

Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.

Key trends

Past 5 years